Case File №
#VI-2026-0295
Peptide Partners
Vendor-Supplied Policies
Exhibit I
Compounds on File
45 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Ipamorelin | A Great | 7 | 9.9 | 9.4 | 10.0 | 23 Oct 2025 |
| BPC-157 | A Great | 7 | 8.0 | 6.9 | 10.0 | 23 Oct 2025 |
| Retatrutide | A Great | 16 | 8.8 | 6.7 | 10.0 | 17 Jul 2025 |
| TB-500 | A Great | 7 | 8.2 | 6.5 | 10.0 | 30 Jan 2026 |
| Tesamorelin | B Good | 11 | 7.8 | 5.3 | 10.0 | 30 Jan 2026 |
| CJC-1295 | C Okay | 9 | 6.7 | 4.3 | 9.4 | 4 Nov 2025 |
| Tirzepatide | C Okay | 6 | 8.2 | 4.2 | 9.8 | 11 Jun 2025 |
| 5-amino-1MQ | X N/A | 1 | 7.6 | 7.6 | 7.6 | 28 Mar 2025 |
| Andarine (S-4) Raw | X N/A | 3 | 7.3 | 5.6 | 8.9 | 17 May 2026 |
| ARA-290 | X N/A | 2 | 7.2 | 6.9 | 7.5 | 21 May 2026 |
| Aromasin (Exemestane) | X N/A | 2 | 8.2 | 7.0 | 9.5 | 20 May 2026 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 4 | 8.6 | 6.6 | 9.9 | 25 May 2026 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 2 | 8.3 | 6.7 | 10.0 | 20 May 2026 |
| Cabergoline | X N/A | 6 | 8.3 | 6.3 | 9.9 | 17 May 2026 |
| Cartalax | X N/A | 2 | 9.6 | 9.2 | 10.0 | 21 May 2026 |
| Cerebrolysin | X N/A | 4 | 7.8 | 6.8 | 10.0 | 17 May 2026 |
| Clenbuterol | X N/A | 3 | 8.4 | 7.5 | 9.7 | 25 May 2026 |
| Clomid | X N/A | 3 | 8.4 | 6.9 | 9.8 | 19 Jan 2026 |
| DHB (1-Test Cyp) Oral | X N/A | 1 | 7.7 | 7.7 | 7.7 | 13 Jun 2025 |
| DNP | X N/A | 5 | 8.0 | 6.5 | 9.3 | 25 May 2026 |
| Drostanolone Enanthate (Mast E) Raw | X N/A | 4 | 8.8 | 6.3 | 10.0 | 23 May 2026 |
| EPO | X N/A | 5 | 9.2 | 7.7 | 10.0 | 20 May 2026 |
| Hexarelin | X N/A | 3 | 7.9 | 6.3 | 10.0 | 19 Jan 2026 |
| HMG | X N/A | 4 | 8.2 | 6.7 | 10.0 | 23 May 2026 |
| Ivermectin | X N/A | 6 | 8.5 | 6.0 | 10.0 | 21 May 2026 |
| KPV Oral | X N/A | 3 | 9.3 | 8.2 | 10.0 | 26 Jan 2026 |
| KPV | X N/A | 6 | 8.1 | 4.8 | 10.0 | 19 Jan 2026 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 8.5 | 8.5 | 8.5 | 2 Jul 2025 |
| Lipo-C FAT BLASTER | X N/A | 5 | 7.2 | 5.2 | 8.8 | 21 May 2026 |
| Minoxidil Oral | X N/A | 6 | 7.8 | 5.6 | 10.0 | 24 May 2026 |
| MT-1 | X N/A | 2 | 6.9 | 4.9 | 8.9 | 20 May 2026 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 5 | 8.8 | 7.0 | 10.0 | 24 May 2026 |
| NAD+ | X N/A | 3 | 9.1 | 7.2 | 10.0 | 23 May 2026 |
| PE 22-28 | X N/A | 2 | 6.8 | 6.2 | 7.3 | 24 May 2026 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | X N/A | 5 | 7.8 | 6.4 | 9.6 | 25 May 2026 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 5 | 7.5 | 6.7 | 8.1 | 17 May 2026 |
| PTD-DBM | X N/A | 6 | 7.8 | 4.7 | 9.5 | 23 May 2026 |
| Retatrutide 30mg Pen Kit | X N/A | 3 | 7.7 | 7.3 | 8.3 | 21 May 2026 |
| Superdrol | X N/A | 6 | 7.7 | 6.5 | 10.0 | 24 May 2026 |
| Tadalafil Raw | X N/A | 1 | 8.3 | 8.3 | 8.3 | 28 Mar 2025 |
| Telmisartan | X N/A | 3 | 8.8 | 8.2 | 10.0 | 21 May 2026 |
| Tesofensine | X N/A | 1 | 9.2 | 9.2 | 9.2 | 21 May 2025 |
| Test Suspension | X N/A | 2 | 9.4 | 8.9 | 10.0 | 23 May 2026 |
| Testosterone Cypionate Raw | X N/A | 6 | 8.8 | 7.2 | 10.0 | 23 May 2026 |
| Thymosin Alpha-1 | X N/A | 5 | 8.2 | 7.6 | 9.0 | 20 May 2026 |
Exhibit II
Evidence Log
143 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Telmisartan | 8.1 A | 20mg | 19.8mg | -0.9% | 98.58% | ix1251 | Lab B | Public |
| 24 May 2026 | Clomid | 8.4 A | 25mg | 21.9mg | -12.3% | 97.46% | miofde | Lab A | Community |
| 24 May 2026 | Testosterone Cypionate Raw | 8.9 A | 5g | 4.4g | -12.4% | 95.03% | 47kqpq | Lab B | Public |
| 24 May 2026 | BPC-157 | X | 7.2 | 10mg | 10.7mg | +7.0% | 98.87% | BP202512 | White Label / Silver Crimp / Yellow Cap |
| 24 May 2026 | TB-500 | Thymosin Beta-4 X | 7.1 | 10mg | 10.7mg | +7.0% | 98.73% | TB202601 | White Label / Silver Crimp / Blue Cap |
| 24 May 2026 | 5-amino-1MQ | 7.6 A | 2mg | 2.3mg | +12.8% | 96.18% | ezl5v7 | Lab A | Community |
| 24 May 2026 | Andarine (S-4) Raw | 7.2 A | 100g | 89.3g | -10.7% | 97.71% | 4j8sed | Lab A | Community |
| 24 May 2026 | EPO | 10.0 A | 5mg | 4.4mg | -12.8% | 96.46% | se60rk | Lab F | Community |
| 24 May 2026 | Ivermectin | 9.8 A | 100mg | 118.2mg | +18.2% | 98.99% | ochj66 | Lab B | Community |
| 24 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 8.7 A | 100g | 90.8g | -9.2% | 99.96% | 3pmib7 | Lab E | Public |
| 24 May 2026 | PTD-DBM | 9.1 A | 30mg | 31.5mg | +5.0% | 99.26% | um8lw5 | Lab B | Public |
| 24 May 2026 | Minoxidil Oral | 8.0 A | 100mg | 90.1mg | -9.9% | 98.98% | 8cn9li | Lab F | Public |
| 24 May 2026 | Minoxidil Oral | 6.8 A | 100mg | 101.7mg | +1.7% | 96.68% | n2r3y9 | Lab G | Community |
| 24 May 2026 | Testosterone Cypionate Raw | 8.6 A | 5g | 4.9g | -2.9% | 95.33% | 1x9azz | Lab B | Public |
| 24 May 2026 | Retatrutide | X | 9.3 | 24mg | 22.3mg | -7.1% | 99.90% | RT202602 | White Label / Silver Crimp / Violet Cap |
| 24 May 2026 | Blend 300 (TRA/Mast P/Test P) | 8.3 A | 200mg/ml | 200.1mg/ml | +0.1% | 97.51% | zq4qtu | Lab G | Public |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 10.0 A | 10mg | 10.9mg | +8.8% | 95.29% | l0rf1w | Lab D | Community |
| 24 May 2026 | Cerebrolysin | 7.1 A | 10mg | 9.3mg | -7.2% | 95.65% | mxctft | Lab B | Community |
| 24 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 8.0 A | 50mg | 42.9mg | -14.2% | 97.43% | l5nddj | Lab B | Community |
| 24 May 2026 | Retatrutide | X | 6.7 | 30mg | 23.9mg | -20.3% | 99.80% | RP260130 | No Label / Silver Crimp / Black Cap |
| 24 May 2026 | KPV | 6.2 A | 15mg | 12.8mg | -14.9% | 99.45% | 7lzgz0 | Lab C | Community |
| 24 May 2026 | NAD+ | 8.4 A | 50mg | 53.3mg | +6.6% | 96.80% | ytagn8 | Lab G | Community |
| 24 May 2026 | NAD+ | 8.6 A | 15mg | 13.6mg | -9.0% | 96.95% | uuic8j | Lab F | Public |
| 24 May 2026 | Primobolan Oral (Methenolone Acetate) | 7.3 A | 20mg | 23.8mg | +18.8% | 99.11% | ncyfsg | Lab G | Community |
| 24 May 2026 | Tadalafil Raw | 9.7 A | 100g | 106.7g | +6.7% | 95.51% | 0o0dpd | Lab A | Community |
| 23 May 2026 | Clenbuterol | 7.3 A | 20mg | 21.4mg | +6.8% | 96.65% | n1vlw9 | Lab G | Community |
| 23 May 2026 | Lipo-C FAT BLASTER | 6.3 A | 300mg/ml | 356.8mg/ml | +18.9% | 95.88% | 6ubqi8 | Lab E | Community |
| 23 May 2026 | Cabergoline | 8.6 A | 20mg | 18.0mg | -10.2% | 99.48% | a3dt1m | Lab B | Public |
| 23 May 2026 | DNP | 8.3 A | 25mg | 26.8mg | +7.3% | 96.66% | lutx7v | Lab G | Community |
| 23 May 2026 | Ivermectin | 8.3 A | 100mg | 96.2mg | -3.8% | 97.41% | u41ag6 | Lab F | Public |
| 23 May 2026 | KPV Oral | 9.7 A | 50mg | 56.0mg | +11.9% | 99.81% | gs1o5l | Lab B | Public |
| 23 May 2026 | Minoxidil Oral | 8.5 A | 10mg | 10.1mg | +1.3% | 96.93% | nid7lo | Lab B | Public |
| 23 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 9.9 A | 20mg | 19.6mg | -2.1% | 99.05% | kv02in | Lab E | Community |
| 23 May 2026 | PE 22-28 | 7.6 A | 2mg | 2.5mg | +23.3% | 99.94% | t93lbx | Lab G | Public |
| 23 May 2026 | Superdrol | 9.1 A | 20mg | 20.8mg | +3.8% | 99.37% | pam19k | Lab C | Community |
| 23 May 2026 | Thymosin Alpha-1 | 9.9 A | 10mg | 12.3mg | +23.4% | 95.81% | lq9nud | Lab F | Community |
| 22 May 2026 | Retatrutide | X | 9.4 | 24mg | 23.3mg | -2.9% | 99.65% | RT202602 | White Label / Silver Crimp / Violet Cap |
| 21 May 2026 | Tesamorelin | X | 6.7 | 10mg | 12.8mg | +28.0% | 99.80% | TES202601 | (no data) |
| 21 May 2026 | Blend 300 (TRA/Mast P/Test P) | 7.3 A | 200mg/ml | 222.7mg/ml | +11.3% | 95.89% | iwglg2 | Lab F | Public |
| 21 May 2026 | HMG | 8.3 A | 5mg | 4.4mg | -11.9% | 95.38% | 8f80zw | Lab A | Public |
| 21 May 2026 | Tesamorelin | X | 5.3 | 10mg | 12mg | +20.0% | 99.14% | TES202601 | White Label / Silver Crimp / Blue Cap |
| 21 May 2026 | DHB (1-Test Cyp) Oral | 6.9 A | 20mg | 22.1mg | +10.4% | 99.69% | ta61rd | Lab C | Public |
| 21 May 2026 | KPV | 8.8 A | 30mg | 30.3mg | +1.1% | 95.23% | zhci70 | Lab F | Public |
| 21 May 2026 | LGD-4033 (Ligandrol) | 9.4 A | 25mg | 28.2mg | +13.0% | 98.31% | q8l98h | Lab A | Community |
| 21 May 2026 | PTD-DBM | 5.6 B | 15mg | 18.7mg | +24.9% | 95.75% | xa5gzd | Lab A | Public |
| 21 May 2026 | Telmisartan | 8.5 A | 50mg | 52.5mg | +4.9% | 98.23% | 4nrd7p | Lab D | Public |
| 20 May 2026 | Cabergoline | 8.7 A | 10mg | 11.6mg | +16.3% | 98.33% | jqvgrg | Lab C | Public |
| 20 May 2026 | HMG | 7.9 A | 30mg | 33.4mg | +11.2% | 98.09% | nhz2ut | Lab D | Public |
| 20 May 2026 | Retatrutide 30mg Pen Kit | 7.9 A | 20mg | 20.6mg | +3.2% | 95.82% | kzt1bk | Lab A | Public |
| 20 May 2026 | Test Suspension | 8.6 A | 250mg/ml | 264.5mg/ml | +5.8% | 98.71% | cc80wf | Lab B | Public |
| 20 May 2026 | Thymosin Alpha-1 | 7.4 A | 50mg | 44.3mg | -11.5% | 96.17% | ppoe4g | Lab A | Public |
| 19 May 2026 | BPC157 5mg + TB500 5mg Blend | 8.4 A | 20mg | 21.9mg | +9.3% | 99.56% | 46qkbm | Lab C | Community |
| 19 May 2026 | Cerebrolysin | 7.0 A | 20mg | 18.5mg | -7.5% | 97.85% | f4ee5p | Lab D | Public |
| 19 May 2026 | MT-1 | 7.9 A | 50mg | 57.4mg | +14.7% | 97.84% | 3pa6f6 | Lab D | Public |
| 19 May 2026 | Testosterone Cypionate Raw | 9.4 A | 10g | 9.0g | -9.9% | 99.74% | 0l717b | Lab D | Public |
| 17 May 2026 | Drostanolone Enanthate (Mast E) Raw | 7.1 A | 5g | 6.2g | +24.0% | 96.37% | mtzxxp | Lab B | Public |
| 17 May 2026 | NAD+ | 7.7 A | 10mg | 10.0mg | -0.1% | 96.17% | t3uyau | Lab C | Community |
| 17 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 7.2 A | 5g | 5.1g | +2.4% | 97.32% | 6m6pw6 | Lab C | Community |
| 17 May 2026 | Superdrol | 9.8 A | 10mg | 9.6mg | -4.0% | 99.69% | ukqlzs | Lab E | Public |
| 17 May 2026 | Testosterone Cypionate Raw | 9.2 A | 500g | 615.9g | +23.2% | 95.74% | h2cdji | Lab A | Community |
| 29 Jan 2026 | Clenbuterol | 8.2 A | 100mg | 99.3mg | -0.7% | 96.68% | eracre | Lab C | Public |
| 29 Jan 2026 | Retatrutide 30mg Pen Kit | 9.5 A | 30mg | 30.7mg | +2.5% | 96.90% | p9c8u6 | Lab D | Community |
| 26 Jan 2026 | Andarine (S-4) Raw | 5.4 B | 1g | 1.0g | +1.7% | 99.55% | n0ifdz | Lab E | Community |
| 26 Jan 2026 | Aromasin (Exemestane) | 7.4 A | 25mg | 29.8mg | +19.2% | 95.04% | hm705u | Lab B | Community |
| 26 Jan 2026 | MT-1 | 6.4 A | 5mg | 4.8mg | -4.7% | 99.09% | g83wcq | Lab A | Community |
| 26 Jan 2026 | PTD-DBM | 9.8 A | 15mg | 18.7mg | +25.0% | 97.12% | cpxmzd | Lab B | Community |
| 19 Jan 2026 | Clenbuterol | 9.9 A | 100mg | 110.2mg | +10.2% | 97.92% | ov9sd1 | Lab D | Community |
| 19 Jan 2026 | EPO | 8.1 A | 10mg | 10.2mg | +1.8% | 98.21% | uqcgfl | Lab G | Community |
| 19 Jan 2026 | KPV | 8.8 A | 50mg | 56.0mg | +12.0% | 99.36% | pic181 | Lab C | Public |
| 19 Jan 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 7.0 A | 10g | 12.4g | +24.2% | 97.86% | qtidb8 | Lab D | Public |
| 19 Jan 2026 | Thymosin Alpha-1 | 9.7 A | 50mg | 45.8mg | -8.4% | 98.02% | a3p7cu | Lab D | Public |
| 9 Jan 2026 | Cartalax | 9.2 A | 10mg | 8.8mg | -12.1% | 96.72% | bh3dsr | Lab E | Public |
| 9 Jan 2026 | Drostanolone Enanthate (Mast E) Raw | 9.1 A | 100g | 92.2g | -7.8% | 99.77% | m428kw | Lab F | Community |
| 9 Jan 2026 | EPO | 8.3 A | 50mg | 55.6mg | +11.1% | 96.02% | bf4q70 | Lab C | Public |
| 9 Jan 2026 | Ivermectin | 10.0 A | 100mg | 87.1mg | -12.9% | 98.53% | dsej9b | Lab D | Public |
| 9 Jan 2026 | KPV | 8.6 A | 30mg | 36.9mg | +23.0% | 95.60% | 3mp6f1 | Lab A | Community |
| 9 Jan 2026 | Lipo-C FAT BLASTER | 9.1 A | 300mg/ml | 260.4mg/ml | -13.2% | 97.34% | g2e7w4 | Lab C | Public |
| 9 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 10.0 A | 5mg | 5.8mg | +15.7% | 95.56% | 0gs6bg | Lab F | Public |
| 9 Jan 2026 | PTD-DBM | 8.2 A | 30mg | 32.5mg | +8.3% | 99.58% | i9sahe | Lab D | Community |
| 9 Jan 2026 | Telmisartan | 10.0 A | 100mg | 102.6mg | +2.6% | 97.42% | fng94b | Lab G | Public |
| 7 Jan 2026 | Drostanolone Enanthate (Mast E) Raw | 9.2 A | 500g | 477.3g | -4.5% | 97.12% | xldc4e | Lab G | Public |
| 7 Jan 2026 | EPO | 9.0 A | 30mg | 29.2mg | -2.7% | 97.66% | fxr4d1 | Lab E | Community |
| 7 Jan 2026 | Lipo-C FAT BLASTER | 6.2 A | 100mg/ml | 111.4mg/ml | +11.4% | 95.51% | kim2bh | Lab D | Public |
| 6 Jan 2026 | DNP | 7.1 A | 50mg | 52.8mg | +5.7% | 97.99% | x9gwlp | Lab B | Community |
| 6 Jan 2026 | DNP | 7.8 A | 10mg | 10.9mg | +8.8% | 95.52% | djsjk1 | Lab C | Public |
| 6 Jan 2026 | Ivermectin | 9.1 A | 10mg | 9.9mg | -0.8% | 97.47% | wk2p2n | Lab D | Community |
| 6 Jan 2026 | Primobolan Oral (Methenolone Acetate) | 8.9 A | 20mg | 23.1mg | +15.3% | 97.30% | me3y2g | Lab F | Public |
| 6 Jan 2026 | PTD-DBM | 6.6 A | 10mg | 10.2mg | +1.8% | 97.42% | k0szty | Lab F | Public |
| 29 Dec 2025 | Cartalax | 10.0 A | 5mg | 5.0mg | +0.8% | 99.11% | l4c902 | Lab F | Public |
| 29 Dec 2025 | Minoxidil Oral | 8.1 A | 100mg | 103.1mg | +3.1% | 99.24% | x8i52w | Lab E | Public |
| 29 Dec 2025 | Superdrol | 9.9 A | 25mg | 25.3mg | +1.3% | 95.36% | njpkm3 | Lab C | Community |
| 12 Dec 2025 | Andarine (S-4) Raw | 6.4 A | 100g | 98.1g | -1.9% | 95.15% | t08gzr | Lab E | Public |
| 12 Dec 2025 | HMG | 9.7 A | 5mg | 5.1mg | +3.0% | 96.75% | v4pavz | Lab G | Public |
| 12 Dec 2025 | KPV | 9.1 A | 50mg | 58.6mg | +17.2% | 96.37% | pq4wcw | Lab D | Community |
| 12 Dec 2025 | Minoxidil Oral | 8.7 A | 100mg | 120.6mg | +20.6% | 97.13% | yjpny4 | Lab G | Community |
| 12 Dec 2025 | Thymosin Alpha-1 | 8.1 A | 5mg | 4.4mg | -11.9% | 97.80% | ek1mna | Lab F | Community |
| 5 Dec 2025 | Blend 300 (TRA/Mast P/Test P) | 6.6 A | 250mg/ml | 243.4mg/ml | -2.7% | 97.58% | 7i2ie4 | Lab B | Community |
| 5 Dec 2025 | Cabergoline | 8.2 A | 100mg | 106.8mg | +6.8% | 97.68% | p5a7pw | Lab C | Public |
| 5 Dec 2025 | Cerebrolysin | 9.1 A | 15mg | 14.8mg | -1.4% | 95.80% | 7q1no7 | Lab C | Community |
| 23 Nov 2025 | ARA-290 | 8.0 A | 30mg | 32.8mg | +9.3% | 95.71% | grujuv | Lab A | Public |
| 23 Nov 2025 | Blend 300 (TRA/Mast P/Test P) | 9.9 A | 250mg/ml | 280.8mg/ml | +12.3% | 95.59% | 1nes7w | Lab C | Community |
| 23 Nov 2025 | Drostanolone Enanthate (Mast E) Raw | 10.0 A | 1g | 1.1g | +5.6% | 97.73% | ohybw4 | Lab C | Community |
| 23 Nov 2025 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 8.0 A | 100g | 111.8g | +11.8% | 97.38% | ql3url | Lab C | Community |
| 23 Nov 2025 | Retatrutide 30mg Pen Kit | 6.3 A | 20mg | 22.8mg | +14.1% | 95.39% | ewbziw | Lab B | Community |
| 23 Nov 2025 | Superdrol | 9.2 A | 25mg | 29.8mg | +19.1% | 98.82% | u8lt1x | Lab E | Community |
| 17 Nov 2025 | Cerebrolysin | 7.2 A | 20mg | 21.5mg | +7.4% | 98.66% | 3b29kt | Lab C | Community |
| 17 Nov 2025 | Clomid | 8.3 A | 20mg | 23.1mg | +15.6% | 96.86% | xcu3iy | Lab C | Community |
| 17 Nov 2025 | DNP | 6.8 A | 100mg | 108.0mg | +8.0% | 97.58% | hem4ng | Lab F | Community |
| 17 Nov 2025 | EPO | 7.4 A | 5mg | 4.4mg | -11.8% | 99.96% | era8d9 | Lab E | Public |
| 17 Nov 2025 | Hexarelin | 8.8 A | 20mg | 22.7mg | +13.7% | 95.97% | lbp2ko | Lab D | Public |
| 17 Nov 2025 | Hexarelin | 8.8 A | 10mg | 9.3mg | -6.7% | 95.13% | m5m8pj | Lab E | Community |
| 17 Nov 2025 | Lipo-C FAT BLASTER | 6.4 A | 100mg/ml | 92.6mg/ml | -7.4% | 98.73% | 3mj57u | Lab A | Public |
| 17 Nov 2025 | PE 22-28 | 9.9 A | 10mg | 8.9mg | -11.0% | 95.79% | 9z5nv8 | Lab E | Community |
| 17 Nov 2025 | Tesofensine | 8.7 A | 10mg | 9.4mg | -5.6% | 95.73% | wiar17 | Lab C | Community |
| 14 Nov 2025 | Cabergoline | 7.8 A | 20mg | 21.3mg | +6.5% | 99.24% | zrgu7m | Lab D | Community |
| 14 Nov 2025 | Cabergoline | 6.9 A | 25mg | 26.8mg | +7.4% | 96.41% | 5u15a0 | Lab G | Community |
| 14 Nov 2025 | DNP | 8.1 A | 50mg | 48.5mg | -3.1% | 97.09% | 8zeoig | Lab C | Community |
| 14 Nov 2025 | Primobolan Oral (Methenolone Acetate) | 8.1 A | 100mg | 89.9mg | -10.1% | 96.31% | c8by65 | Lab D | Public |
| 14 Nov 2025 | PTD-DBM | 7.6 A | 20mg | 22.7mg | +13.5% | 98.72% | is52nm | Lab G | Community |
| 14 Nov 2025 | Superdrol | 7.2 A | 25mg | 26.9mg | +7.7% | 97.05% | kcr4z4 | Lab F | Public |